Search hospitals > California > Palo Alto
VA Palo Alto Health Care System
Claim this profilePalo Alto, California 94304
Global Leader in Post-Traumatic Stress Disorder
Global Leader in Depression
Conducts research for Cancer
Conducts research for Traumatic Stress Disorders
Conducts research for Sleep Disorders
299 reported clinical trials
30 medical researchers
Summary
VA Palo Alto Health Care System is a medical facility located in Palo Alto, California. This center is recognized for care of Post-Traumatic Stress Disorder, Depression, Cancer, Traumatic Stress Disorders, Sleep Disorders and other specialties. VA Palo Alto Health Care System is involved with conducting 299 clinical trials across 376 conditions. There are 30 research doctors associated with this hospital, such as Manali I Patel, MD MPH MS, Harlan A. Pinto, Shipra Arya, MD, and Daniel M. Blonigen, PhD MA.Top PIs
Manali I Patel, MD MPH MSStanford University School of Medicine2 years of reported clinical research
Studies Cancer
Studies End of Life
7 reported clinical trials
8 drugs studied
Harlan A. PintoVA Palo Alto Health Care System7 years of reported clinical research
Studies Cancer
Studies Recurrence
7 reported clinical trials
32 drugs studied
Shipra Arya, MDVA Palo Alto Health Care System, Palo Alto, CA2 years of reported clinical research
Studies Frailty
Studies Acute Kidney Injury
3 reported clinical trials
6 drugs studied
Daniel M. Blonigen, PhD MAVA Palo Alto Health Care System, Palo Alto, CA3 years of reported clinical research
Studies Substance Use Disorder
Studies Substance Use Disorders
3 reported clinical trials
5 drugs studied
Clinical Trials running at VA Palo Alto Health Care System
Squamous Cell Carcinoma
Post-Traumatic Stress Disorder
Cancer
Traumatic Stress Disorders
Osteoarthritis
Substance Use Disorders
Opioid Use Disorder
Parkinson's Disease
Mental Illness
Kidney Disease
Pre-Surgery Chemotherapy + Surgery & Radiation
for Sinus Cancer
This randomized phase II trial studies how well chemotherapy before surgery and radiation therapy works compared to surgery and radiation therapy alone in treating patients with nasal and paranasal sinus cancer that can be removed by surgery. Drugs used in chemotherapy, such as docetaxel, cisplatin, and carboplatin work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy before surgery and radiation therapy may make the tumor smaller and reduce the amount of normal tissue that needs to be removed and treated with radiation.
Recruiting1 award Phase 2
Atezolizumab + Bevacizumab
for Advanced Head and Neck Cancer
This phase II/III compares the standard therapy (chemotherapy plus cetuximab) versus adding bevacizumab to standard chemotherapy, versus combination of just bevacizumab and atezolizumab in treating patients with head and neck cancer that has spread to other places in the body (metastatic or advanced stage) or has come back after prior treatment (recurrent). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of cancer cells. This may help keep cancer cells from growing. Cisplatin and carboplatin are in a class of chemotherapy medications known as platinum-containing compounds. They work by killing, stopping, or slowing the growth of cancer cells. Docetaxel is in a class of chemotherapy medications called taxanes. It stops cancer cells from growing and dividing and may kill them. The addition of bevacizumab to standard chemotherapy or combination therapy with bevacizumab and atezolizumab may be better than standard chemotherapy plus cetuximab in treating patients with recurrent/metastatic head and neck cancers.
Recruiting1 award Phase 2 & 344 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at VA Palo Alto Health Care System?
VA Palo Alto Health Care System is a medical facility located in Palo Alto, California. This center is recognized for care of Post-Traumatic Stress Disorder, Depression, Cancer, Traumatic Stress Disorders, Sleep Disorders and other specialties. VA Palo Alto Health Care System is involved with conducting 299 clinical trials across 376 conditions. There are 30 research doctors associated with this hospital, such as Manali I Patel, MD MPH MS, Harlan A. Pinto, Shipra Arya, MD, and Daniel M. Blonigen, PhD MA.